Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in Northern Finland

Gynecologic and Obstetric Investigation

Volumn 62, Issue 1, 2006, Pages 28-32

  Jarvenpaa, J ^a   Pakkila, M ^a   Savolainen, E R ^b   Perheentupa, A ^a   Jarvela, I ^a   Ryynanen, M ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Factor V Leiden mutation; Preeclampsia; Pregnancy complications; Thrombophilic genes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; FACTOR II GENE; FEMALE; FETUS DEATH; FINLAND; FVL GENE; GENE; GENE MUTATION; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MTHFR GENE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

CASE-CONTROL STUDIES; FACTOR V; FEMALE; FINLAND; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREVALENCE; PROTHROMBIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33745699903     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091814     Document Type: Article

References (29)

1. Salafia CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, et al: Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation. Am J Perinatol 1995;12:429-436.
2. Brenner B: Haemostatic changes in pregnancy. Thromb Res 2004;114:409-414.
3. Clark P: Changes of hemostasis variables during pregnancy. Semin Vasc Med 2003;3:13-24.
4. Walker ID: Congenital thrombophilia. Baillières Clin Obstet Gynaecol 1997;11:431-445.
5. Pastinen T, Perola M, Ignatius J, Sabatti C, Tainola P, Levander M, et al: Dissecting a population genome for targeted screening of disease mutations. Hum Mol Genet 2001;10:2961-2972.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
7. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, et al: Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-824.
8. Agorastos T, Karavida A, Lambropoulos A, Constantinidis T, Tzitzimikas S, Chrisafi S, et al: Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 2002;12:267-273.
9. Kupfermine MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A: High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79:963-967.
10. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, et al: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313:709-715.
11. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-150.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
13. Blom HJ: Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia. Eur J Pediatr 1998;157:S131-134.
14. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, et al: Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23-29.
15. Greer IA: Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258-1265.
16. McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA: Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG 2000;107:565-569.
17. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B: Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997;176:457-460.
18. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al: Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
19. Spina V, Aleandri V, Morini F: The impact of the factor V Leiden mutation on pregnancy. Hum Reprod Update 2000;6:301-306.
20. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, et al: Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999;181:975-980.
21. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, et al: Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002;87:779-785.
22. Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, et al: Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001;86:428-431.
23. Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, et al: Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002;347:19-25.
24. McCowan LM, Craigie S, Taylor RS, Ward C, McLintock C, North RA: Inherited thrombophilias are not increased in 'idiopathic' small-for- gestational-age pregnancies. Am J Obstet Gynecol 2003;188:981-985.
25. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al: Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-916.
26. Ogunyemi D, Ku W, Arkel Y: The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy. J Thromb Thrombolysis 2002;14:157-162.
27. Kaiser T, Brennecke SP, Moses EK: C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Hum Hered 2001;51:20-22.
28. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K: 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 2000;96:277-280.
29. Lin J, August P, Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005;105:182-192.